The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/II dose escalation and expansion study of cabiralizumab (cabira; FPA-008), an anti-CSF1R antibody, in tenosynovial giant cell tumor (TGCT, diffuse pigmented villonodular synovitis D-PVNS).
 
Kamalesh Kumar Sankhala
No Relationships to Disclose
 
Jean-Yves Blay
Consulting or Advisory Role - Novartis Pharmaceuticals UK Ltd.; Plexxikon; Roche/Genentech
Research Funding - Novartis Pharmaceuticals UK Ltd.; Plexxikon; Roche/Genentech
 
Kristen N. Ganjoo
Consulting or Advisory Role - Novartis Pharmaceuticals UK Ltd.
 
Antoine Italiano
No Relationships to Disclose
 
Andrew Bassim Hassan
No Relationships to Disclose
 
Tae Min Kim
No Relationships to Disclose
 
Vinod Ravi
Consulting or Advisory Role - Lilly
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - UpToDate
 
Philippe Alexandre Cassier
Honoraria - Amgen; Blueprint Medicines; Novartis; Roche/Genentech
Research Funding - AstraZeneca (Inst); Bayer (Inst); Blueprint Medicines (Inst); Celgene (Inst); Lilly (Inst); Novartis (Inst); Plexxikon (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Amgen; Novartis; Roche
 
Piotr Rutkowski
Honoraria - Bristol-Myers Squibb; GlaxoSmithKline; MSD Oncology; Novartis; Roche/Genentech
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; MSD Oncology; Roche/Genentech
Speakers' Bureau - MSD; Novartis; Pfizer; Roche/Genentech
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Novartis
 
Neil Sankar
Employment - Five Prime Therapeutics
Stock and Other Ownership Interests - Five Prime Therapeutics
 
Ibrahim Qazi
Employment - Five Prime Therapeutics
Stock and Other Ownership Interests - Exelixis; Five Prime Therapeutics
Travel, Accommodations, Expenses - Five Prime Therapeutics
 
Robert S. Sikorski
Employment - Five Prime Therapeutics
Stock and Other Ownership Interests - Five Prime Therapeutics
 
Helen Collins
Employment - Five Prime Therapeutics; Gilead Sciences; Jazz Pharmaceuticals (I)
Stock and Other Ownership Interests - Five Prime Therapeutics; Gilead Sciences; Jazz Pharmaceuticals (I)
 
Charlie Zhang
Employment - Five Prime Therapeutics
Stock and Other Ownership Interests - Five Prime Therapeutics
 
Ellyn Shocron
Employment - Five Prime Therapeutics
Stock and Other Ownership Interests - Five Prime Therapeutics
 
Hans Gelderblom
No Relationships to Disclose